日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome

WT1-mRNA树突状细胞疫苗接种治疗多形性胶质母细胞瘤、恶性胸膜间皮瘤、转移性乳腺癌和其他实体瘤患者:1型T淋巴细胞反应与临床疗效相关

Berneman, Zwi N; De Laere, Maxime; Germonpré, Paul; Huizing, Manon T; Willemen, Yannick; Lion, Eva; De Reu, Hans; Van den Bossche, Jolien; Van den Brande, Jan; Specenier, Pol; Altintas, Sevilay; van Dam, Peter A; Cools, Nathalie; Nijs, Griet; Stein, Barbara; Caluwaerts, Kim; Snoeckx, Annemiek; Op de Beeck, Bart; Saevels, Kirsten; Rutsaert, Lynn; Vandenbosch, Irma; Oner, Gizem; Lammens, Martin; Van Damme, Pierre; Llewellyn-Lacey, Sian; Price, David A; Oka, Yoshihiro; Oji, Yusuke; Sugiyama, Haruo; Couttenye, Marie M; Van de Velde, Ann L; Van Tendeloo, Viggo F; Peeters, Marc; Anguille, Sébastien; Smits, Evelien L J M

Correction: WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome

更正:WT1-mRNA树突状细胞疫苗接种治疗多形性胶质母细胞瘤、恶性胸膜间皮瘤、转移性乳腺癌和其他实体瘤患者:1型T淋巴细胞反应与临床结果相关

Berneman, Zwi N; De Laere, Maxime; Germonpré, Paul; Huizing, Manon T; Willemen, Yannick; Lion, Eva; De Reu, Hans; Van den Bossche, Jolien; Van den Brande, Jan; Specenier, Pol; Altintas, Sevilay; van Dam, Peter A; Cools, Nathalie; Nijs, Griet; Stein, Barbara; Caluwaerts, Kim; Snoeckx, Annemiek; de Beeck, Bart Op; Saevels, Kirsten; Rutsaert, Lynn; Vandenbosch, Irma; Oner, Gizem; Lammens, Martin; Van Damme, Pierre; Llewellyn-Lacey, Sian; Price, David A; Oka, Yoshihiro; Oji, Yusuke; Sugiyama, Haruo; Couttenye, Marie M; Van de Velde, Ann L; Van Tendeloo, Viggo F; Peeters, Marc; Anguille, Sébastien; Smits, Evelien L J M

Integration of the PD-L1 inhibitor atezolizumab and WT1/DC vaccination into standard-of-care first-line treatment for patients with epithelioid malignant pleural mesothelioma-Protocol of the Immuno-MESODEC study

将PD-L1抑制剂阿特珠单抗和WT1/DC疫苗整合到上皮样恶性胸膜间皮瘤患者的一线标准治疗方案中——Immuno-MESODEC研究方案

Van den Bossche, Jolien; De Laere, Maxime; Deschepper, Koen; Germonpré, Paul; Valcke, Yvan; Lamont, Jan; Stein, Barbara; Van Camp, Kirsten; Germonpré, Charlotte; Nijs, Griet; Roelant, Ella; Anguille, Sébastien; Lion, Eva; Berneman, Zwi

Adjuvant Wilms' tumour 1-specific dendritic cell immunotherapy complementing conventional therapy for paediatric patients with high-grade glioma and diffuse intrinsic pontine glioma: protocol of a monocentric phase I/II clinical trial in Belgium

辅助性 Wilms 肿瘤 1 特异性树突状细胞免疫疗法可补充常规疗法,用于治疗儿童高级别胶质瘤和弥漫性内生性脑桥胶质瘤:一项在比利时开展的单中心 I/II 期临床试验方案

Van Genechten, Toon; De Laere, Maxime; Van den Bossche, Jolien; Stein, Barbara; De Rycke, Kim; Deschepper, Caroline; Hazes, Katja; Peeters, Renke; Couttenye, Marie-Madeleine; Van De Walle, Katrien; Roelant, Ella; Maes, Sabine; Vanden Bossche, Stephanie; Dekeyzer, Sven; Huizing, Manon; Caluwaert, Kim; Nijs, Griet; Cools, Nathalie; Verlooy, Joris; Norga, Koen; Verhulst, Stijn; Anguille, Sebastien; Berneman, Zwi; Lion, Eva

MDM2 SNP309 and SNP285 Act as Negative Prognostic Markers for Non-small Cell Lung Cancer Adenocarcinoma Patients

MDM2 SNP309 和 SNP285 可作为非小细胞肺癌腺癌患者的不良预后标志物

Deben, Christophe; Op de Beeck, Ken; Van den Bossche, Jolien; Jacobs, Julie; Lardon, Filip; Wouters, An; Peeters, Marc; Van Camp, Guy; Rolfo, Christian; Deschoolmeester, Vanessa; Pauwels, Patrick

Unlocking the potential of CD70 as a novel immunotherapeutic target for non-small cell lung cancer.

揭示 CD70 作为非小细胞肺癌新型免疫治疗靶点的潜力

Jacobs Julie, Zwaenepoel Karen, Rolfo Christian, Van den Bossche Jolien, Deben Christophe, Silence Karen, Hermans Christophe, Smits Evelien, Van Schil Paul, Lardon Filip, Deschoolmeester Vanessa, Pauwels Patrick